Under construction – not a live service
Sign in
Taking people in GermanyPhase 1/2

Tests MB-CART19.1 cell therapy in lupus that has not responded to treatment

Tests MB-CART19.1 cell therapy in adults with treatment-resistant systemic lupus erythematosus.

Key facts

Who runs it
Miltenyi Biomedicine GmbH
Where
Erlangen, Magdeburg, Tuebingen, and Wuerzburg, GermanySee the 4 sites
Registry title
MB-CART19.1 in refractory SLE
Status
Recruiting
Phase
Phase 1/2
People taking part
30 people, planned
Started
12 Aug 2024
Expected to end
30 Nov 2026
Type of study
Interventional
Record updated
15 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with systemic lupus erythematosus (SLE) that has not responded to treatment. It tests MB-CART19.1.

Age
18 years or older
Sex
Women and men can join
Disease stage
Refractory (treatment-resistant) systemic lupus erythematosus

Main reasons for not taking part

  • Healthy volunteers cannot join

Where in Germany

  • Universitaetsklinikum Erlangen AöRErlangen, GermanyTaking people
  • Otto Von Guericke Universitaet MagdeburgMagdeburg, GermanyTaking people
  • Universitaetsklinikum Tuebingen AöRTuebingen, GermanyTaking people
  • Universitaetsklinikum Wuerzburg AöRWuerzburg, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Tests MB-CART19.1 cell therapy in lupus that has not responded to treatmentGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
15 September 2026